Transthyretin Amyloidosis (ATTR) is a life-threatening genetic disorder characterized by the accumulation of amyloid fibrils, primarily composed of transthyretin protein, in the body's organs and tissues. This accumulation leads to progressive organ dysfunction and systemic failures. The introduction of this report will outline the scope of the Transthyretin Amyloidosis Treatment Market, its impact on public health, and the necessity of advanced treatments. The aim is to equip stakeholders with ...